MedPath

Alprazolam

These highlights do not include all the information needed to use ALPRAZOLAM safely and effectively. See full prescribing information for ALPRAZOLAM. ALPRAZOLAM (alprazolam) tablets, for oral use, CIV Initial U.S. Approval: 1981

Approved
Approval ID

4579facb-b225-4108-a5ef-dada926ef7cf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 1, 2022

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

alprazolam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71205-652
Application NumberNDA018276
Product Classification
M
Marketing Category
C73605
G
Generic Name
alprazolam
Product Specifications
Route of AdministrationORAL
Effective DateApril 1, 2022
FDA Product Classification

INGREDIENTS (9)

ALPRAZOLAMActive
Quantity: 0.5 mg in 1 1
Code: YU55MQ3IZY
Classification: ACTIB
POWDERED CELLULOSEInactive
Code: SMD1X3XO9M
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
DOCUSATE SODIUMInactive
Code: F05Q2T2JA0
Classification: IACT
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Alprazolam - FDA Drug Approval Details